These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 11063957)

  • 1. Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance.
    Catena C; Zingaro L; Casaccio D; Sechi LA
    Am J Med; 2000 Nov; 109(7):556-61. PubMed ID: 11063957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of lipoprotein(a) to variables of coagulation in hypertensive subjects.
    Sechi LA; De Marchi S
    J Investig Med; 2001 Jan; 49(1):12-20. PubMed ID: 11217142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased fibrinogen levels and hemostatic abnormalities in patients with arteriolar nephrosclerosis: association with cardiovascular events.
    Sechi LA; Zingaro L; Catena C; De Marchi S
    Thromb Haemost; 2000 Oct; 84(4):565-70. PubMed ID: 11057851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein (a), haemostatic variables and cardiovascular damage in hypertensive patients.
    Sechi LA; Catena C; Casaccio D; Zingaro L
    J Hypertens; 2000 Jun; 18(6):709-16. PubMed ID: 10872555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of fibrinogen levels and hemostatic abnormalities with organ damage in hypertension.
    Sechi LA; Zingaro L; Catena C; Casaccio D; De Marchi S
    Hypertension; 2000 Dec; 36(6):978-85. PubMed ID: 11116111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock.
    Gando S; Nanzaki S; Sasaki S; Aoi K; Kemmotsu O
    Crit Care Med; 1998 Dec; 26(12):2005-9. PubMed ID: 9875912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early decrease in coagulation activity after myocardial infarction is associated with lower risk of new ischaemic events: observations from the ESTEEM Trial.
    Christersson C; Oldgren J; Bylock A; Siegbahn A; Wallentin L
    Eur Heart J; 2007 Mar; 28(6):692-8. PubMed ID: 17314111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation system activated in Duchenne muscular dystrophy patients with cardiac dysfunction.
    Saito T; Yamamoto Y; Matsumura T; Nozaki S; Fujimura H; Shinno S
    Brain Dev; 2005 Sep; 27(6):415-8. PubMed ID: 16122628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood coagulation parameters in retinal arterial occlusion.
    Sagripanti A; Romani A; Ferretti A; Ragone MC; Baicchi U; Carpi A; Nardi M
    Graefes Arch Clin Exp Ophthalmol; 1999 Jun; 237(6):480-3. PubMed ID: 10379608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulation activation in patients with Binswanger disease.
    Tomimoto H; Akiguchi I; Wakita H; Osaki A; Hayashi M; Yamamoto Y
    Arch Neurol; 1999 Sep; 56(9):1104-8. PubMed ID: 10488811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemostatic abnormalities may predict chronic hypertension after preeclampsia.
    Bremme K; Blombäck M
    Gynecol Obstet Invest; 1996; 41(1):20-6. PubMed ID: 8821879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of a prothrombotic state with left-ventricular diastolic dysfunction in hypertension: a tissue-Doppler imaging study.
    Catena C; Colussi G; Fedrizzi S; Sechi LA
    J Hypertens; 2013 Oct; 31(10):2077-84. PubMed ID: 24107736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery.
    Parolari A; Colli S; Mussoni L; Eligini S; Naliato M; Wang X; Gandini S; Tremoli E; Biglioli P; Alamanni F
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):336-43. PubMed ID: 12579103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrarenal Vascular Resistance is Associated With a Prothrombotic State in Hypertensive Patients.
    Catena C; Colussi G; Novello M; Fagotto V; Sechi LA
    Kidney Blood Press Res; 2016; 41(6):929-936. PubMed ID: 27894116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [D-dimer, thrombin-antithrombin III-complex (TAT) and prothrombin fragment 1+2 (PTF). Parameters for monitoring therapy with low molecular-weight heparin in coagulation disorders].
    Hofmann M; Rest A; Hafner G; Tanner B; Brockerhoff P; Weilemann LS
    Anaesthesist; 1997 Aug; 46(8):689-96. PubMed ID: 9382207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation system and platelets are fully activated in uncomplicated sepsis.
    Mavrommatis AC; Theodoridis T; Orfanidou A; Roussos C; Christopoulou-Kokkinou V; Zakynthinos S
    Crit Care Med; 2000 Feb; 28(2):451-7. PubMed ID: 10708182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of prothrombin fragment F1+2, D-dimer and prothrombin time correlate with clinical stage and lymph node metastasis in operable gastric cancer patients.
    Kwon HC; Oh SY; Lee S; Kim SH; Han JY; Koh RY; Kim MC; Kim HJ
    Jpn J Clin Oncol; 2008 Jan; 38(1):2-7. PubMed ID: 18258711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prothrombotic state is associated with early arterial damage in hypertensive patients.
    Catena C; Colussi G; Brosolo G; Sechi LA
    J Atheroscler Thromb; 2012; 19(5):471-8. PubMed ID: 22659531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prothrombin fragment 1.2 and modified antithrombin as predictors of disseminated intravascular coagulation and thrombotic risk in thermal injury.
    Kowal-Vern A; Walenga JM; Hoppensteadt D; Gamelli RL
    J Burn Care Res; 2013; 34(4):459-64. PubMed ID: 23202877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prothrombin fragment 1 + 2 and antithrombin III-thrombin complex in microalbuminuric type 2 diabetic patients.
    Gruden G; Cavallo-Perin P; Romagnoli R; Olivetti C; Frezet D; Pagano G
    Diabet Med; 1994 Jun; 11(5):485-8. PubMed ID: 8088128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.